ENTRY       D00150                      Drug
NAME        Angiotensin II (INN)
REMARK      ATC code: C01CX09
EFFICACY    Vasoconstrictor, Angiotensin II receptor agonist
TARGET      AGTR1 [HSA:185] [KO:K04166]
            AGTR2 [HSA:186] [KO:K04167]
  PATHWAY   hsa04020(185)  Calcium signaling pathway
            hsa04080(185+186)  Neuroactive ligand-receptor interaction
            hsa04261(185+186)  Adrenergic signaling in cardiomyocytes
            hsa04270(185)  Vascular smooth muscle contraction
            hsa04614(185+186)  Renin-angiotensin system
            hsa04924(185)  Renin secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
                C01CX Other cardiac stimulants
                 C01CX09 Angiotensin II
                  D00150  Angiotensin II (INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Angiotensin
                AGTR1
                 D00150  Angiotensin II (INN)
                AGTR2
                 D00150  Angiotensin II (INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00150
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00150
DBLINKS     CAS: 11128-99-7
            PubChem: 7847218
            NIKKAJI: J240.229G
///
